Graft-versus-myeloma effect: Proof of principle

Immunology and Microbiology

• T Cell 100%
• Multiple Myeloma 100%
• Conditioning 100%
• Cyclophosphamide 100%
• Autotransplantation 100%
• Chronic Graft Versus Host Disease 100%
• Graft Versus Tumor Effect 100%
• CD3 Antigen 100%
• Allograft 100%
• Peripheral Blood Mononuclear Cell 100%

Keyphrases

• Graft-versus-leukemia Effect 100%
• Multiple Myeloma 33%
• Myeloma 33%
• Progressive Disease 33%
• Leukemia 33%
• Cyclophosphamide 33%
• Conventional Chemotherapy 33%
• Pretransplant 33%
• Older Patients 33%
• T Cell Depletion 33%
• Complete Remission 33%
• Graft-versus-host Disease (GvHD) 33%
• Transient Response 33%
• Peripheral Blood Mononuclear Cells 33%
• Severe Acute 33%
• 40 Years Old 33%
• Autologous Transplantation 33%
• Cytotoxic Therapy 33%
• Rapidly Progressive 33%
• Allogeneic Transplantation 33%
• Incomplete Response 33%
• Thiotepa 33%
• Fractionated Whole Body gamma Irradiation (FWBGI) 33%
• Matched Unrelated 33%

Medicine and Dentistry

• Myeloma 100%
• Transplantation 33%
• Multiple Myeloma 33%
• Conditioning 33%
• Progressive Disease 33%
• T Cell 33%
• Leukemia 33%
• Allograft 33%
• Cyclophosphamide 33%
• Cytotoxic Chemotherapy 33%
• Peripheral Blood Mononuclear Cell 33%
• Autotransplantation 33%
• Chronic Graft Versus Host Disease 33%
• Graft Versus Tumor Effect 33%
• Whole Body Radiation 33%
• Thiotepa 33%
• CD3 Antigen 33%
• Chemotherapy 33%